When Science Gets in the Way of Pet Agendas

On June 11, the Centers for Disease Control and Prevention in Atlanta issued a report about StarLink corn.1 Remember StarLink? Marketed by Aventis Seeds, it contained a gene from the soil bacterium Bacillus thuringiensis, or Bt. The Cry9C protein encoded by the gene rendered the plants resistant to chewing insects. But unlike other varieties of Bt corn, StarLink was not approved for human consumption because of questions about potential allergenicity. Data provided to the Environmental Protectio

Written byBarry Palevitz
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

EPA erred badly--in hindsight, it's not surprising that StarLink made its way into the human food stream. Last September, a genetic testing lab hired by environmental activists detected StarLink's DNA fingerprint in tacos distributed by Kraft Foods. A subsequent search led the Food and Drug Administration (FDA) to recall hundreds of corn products, and Aventis cringed at a clean up bill of $1 billion. The media went into a feeding frenzy and environmental groups like Greenpeace and Environmental Defense (ED) that are opposed to genetically modified crops had a field day. About 50 people claimed they were sickened after eating the corn.

But did those people really react to Cry9C protein? Scientists agreed the possibility of an allergic response was slim. The levels of food borne Cry9C protein if any were low, and besides, it hadn't been around that long. You have to have been exposed to an antigen beforehand ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies